No Data
No Data
Are Medlive Technology Co., Ltd.'s (HKG:2192) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
With its stock down 7.4% over the past three months, it is easy to disregard Medlive Technology (HKG:2192). But if you pay close attention, you might find that its key financial indicators look quit
There's Reason For Concern Over Medlive Technology Co., Ltd.'s (HKG:2192) Price
When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 9x, you may consider Medlive Technology Co., Ltd. (HKG:2192) as a stock to avoid entirely with its 24.2x
We Think That There Are Issues Underlying Medlive Technology's (HKG:2192) Earnings
Medlive Technology Co., Ltd. (HKG:2192) announced strong profits, but the stock was stagnant. Our analysis suggests that this might be because shareholders have noticed some concerning underlying fac
Medlive Technology More Than Doubles Profit in 2023
Medlive Technology (HKG:2192) recorded a 107% rise in attributable profit for the year ended Dec. 31, 2023, to 242.3 million yuan from 117.3 million yuan in 2022, according to the company's annual rep
MEDLIVE: ANNUAL REPORT 2023
Medlive Technology Co., Ltd. (HKG:2192) Full-Year Results: Here's What Analysts Are Forecasting For This Year
As you might know, Medlive Technology Co., Ltd. (HKG:2192) recently reported its full-year numbers. The result was positive overall - although revenues of CN¥412m were in line with what the anal
No Data
冷暖自知 : Very good return, long term or short term?